The CloudUPDRS smartphone software in Parkinson’s study: cross-validation against blinded human raters

Abstract Digital assessments of motor severity could improve the sensitivity of clinical trials and personalise treatment in Parkinson’s disease (PD) but have yet to be widely adopted. Their ability to capture individual change across the heterogeneous motor presentations typical of PD remains inade...

Full description

Bibliographic Details
Main Authors: Ashwani Jha, Elisa Menozzi, Rebecca Oyekan, Anna Latorre, Eoin Mulroy, Sebastian R. Schreglmann, Cosmin Stamate, Ioannis Daskalopoulos, Stefan Kueppers, Marco Luchini, John C. Rothwell, George Roussos, Kailash P. Bhatia
Format: Article
Language:English
Published: Nature Publishing Group 2020-12-01
Series:npj Parkinson's Disease
Online Access:https://doi.org/10.1038/s41531-020-00135-w
id doaj-dbd853c5a047468e8202a0decd920ae5
record_format Article
spelling doaj-dbd853c5a047468e8202a0decd920ae52020-12-13T12:41:25ZengNature Publishing Groupnpj Parkinson's Disease2373-80572020-12-01611810.1038/s41531-020-00135-wThe CloudUPDRS smartphone software in Parkinson’s study: cross-validation against blinded human ratersAshwani Jha0Elisa Menozzi1Rebecca Oyekan2Anna Latorre3Eoin Mulroy4Sebastian R. Schreglmann5Cosmin Stamate6Ioannis Daskalopoulos7Stefan Kueppers8Marco Luchini9John C. Rothwell10George Roussos11Kailash P. Bhatia12Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of NeurologyDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of NeurologyDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of NeurologyDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of NeurologyDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of NeurologyDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of NeurologyBirkbeck College, University of LondonBirkbeck College, University of LondonBirkbeck College, University of LondonBenchmark Performance LtdDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of NeurologyQueen Square Movement Disorders Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of NeurologyDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of NeurologyAbstract Digital assessments of motor severity could improve the sensitivity of clinical trials and personalise treatment in Parkinson’s disease (PD) but have yet to be widely adopted. Their ability to capture individual change across the heterogeneous motor presentations typical of PD remains inadequately tested against current clinical reference standards. We conducted a prospective, dual-site, crossover-randomised study to determine the ability of a 16-item smartphone-based assessment (the index test) to predict subitems from the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale part III (MDS-UPDRS III) as assessed by three blinded clinical raters (the reference-standard). We analysed data from 60 subjects (990 smartphone tests, 2628 blinded video MDS-UPDRS III subitem ratings). Subject-level predictive performance was quantified as the leave-one-subject-out cross-validation (LOSO-CV) accuracy. A pre-specified analysis classified 70.3% (SEM 5.9%) of subjects into a similar category to any of three blinded clinical raters and was better than random (36.7%; SEM 4.3%) classification. Post hoc optimisation of classifier and feature selection improved performance further (78.7%, SEM 5.1%), although individual subtests were variable (range 53.2–97.0%). Smartphone-based measures of motor severity have predictive value at the subject level. Future studies should similarly mitigate against subjective and feature selection biases and assess performance across a range of motor features as part of a broader strategy to avoid overly optimistic performance estimates.https://doi.org/10.1038/s41531-020-00135-w
collection DOAJ
language English
format Article
sources DOAJ
author Ashwani Jha
Elisa Menozzi
Rebecca Oyekan
Anna Latorre
Eoin Mulroy
Sebastian R. Schreglmann
Cosmin Stamate
Ioannis Daskalopoulos
Stefan Kueppers
Marco Luchini
John C. Rothwell
George Roussos
Kailash P. Bhatia
spellingShingle Ashwani Jha
Elisa Menozzi
Rebecca Oyekan
Anna Latorre
Eoin Mulroy
Sebastian R. Schreglmann
Cosmin Stamate
Ioannis Daskalopoulos
Stefan Kueppers
Marco Luchini
John C. Rothwell
George Roussos
Kailash P. Bhatia
The CloudUPDRS smartphone software in Parkinson’s study: cross-validation against blinded human raters
npj Parkinson's Disease
author_facet Ashwani Jha
Elisa Menozzi
Rebecca Oyekan
Anna Latorre
Eoin Mulroy
Sebastian R. Schreglmann
Cosmin Stamate
Ioannis Daskalopoulos
Stefan Kueppers
Marco Luchini
John C. Rothwell
George Roussos
Kailash P. Bhatia
author_sort Ashwani Jha
title The CloudUPDRS smartphone software in Parkinson’s study: cross-validation against blinded human raters
title_short The CloudUPDRS smartphone software in Parkinson’s study: cross-validation against blinded human raters
title_full The CloudUPDRS smartphone software in Parkinson’s study: cross-validation against blinded human raters
title_fullStr The CloudUPDRS smartphone software in Parkinson’s study: cross-validation against blinded human raters
title_full_unstemmed The CloudUPDRS smartphone software in Parkinson’s study: cross-validation against blinded human raters
title_sort cloudupdrs smartphone software in parkinson’s study: cross-validation against blinded human raters
publisher Nature Publishing Group
series npj Parkinson's Disease
issn 2373-8057
publishDate 2020-12-01
description Abstract Digital assessments of motor severity could improve the sensitivity of clinical trials and personalise treatment in Parkinson’s disease (PD) but have yet to be widely adopted. Their ability to capture individual change across the heterogeneous motor presentations typical of PD remains inadequately tested against current clinical reference standards. We conducted a prospective, dual-site, crossover-randomised study to determine the ability of a 16-item smartphone-based assessment (the index test) to predict subitems from the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale part III (MDS-UPDRS III) as assessed by three blinded clinical raters (the reference-standard). We analysed data from 60 subjects (990 smartphone tests, 2628 blinded video MDS-UPDRS III subitem ratings). Subject-level predictive performance was quantified as the leave-one-subject-out cross-validation (LOSO-CV) accuracy. A pre-specified analysis classified 70.3% (SEM 5.9%) of subjects into a similar category to any of three blinded clinical raters and was better than random (36.7%; SEM 4.3%) classification. Post hoc optimisation of classifier and feature selection improved performance further (78.7%, SEM 5.1%), although individual subtests were variable (range 53.2–97.0%). Smartphone-based measures of motor severity have predictive value at the subject level. Future studies should similarly mitigate against subjective and feature selection biases and assess performance across a range of motor features as part of a broader strategy to avoid overly optimistic performance estimates.
url https://doi.org/10.1038/s41531-020-00135-w
work_keys_str_mv AT ashwanijha thecloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters
AT elisamenozzi thecloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters
AT rebeccaoyekan thecloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters
AT annalatorre thecloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters
AT eoinmulroy thecloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters
AT sebastianrschreglmann thecloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters
AT cosminstamate thecloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters
AT ioannisdaskalopoulos thecloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters
AT stefankueppers thecloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters
AT marcoluchini thecloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters
AT johncrothwell thecloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters
AT georgeroussos thecloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters
AT kailashpbhatia thecloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters
AT ashwanijha cloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters
AT elisamenozzi cloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters
AT rebeccaoyekan cloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters
AT annalatorre cloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters
AT eoinmulroy cloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters
AT sebastianrschreglmann cloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters
AT cosminstamate cloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters
AT ioannisdaskalopoulos cloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters
AT stefankueppers cloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters
AT marcoluchini cloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters
AT johncrothwell cloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters
AT georgeroussos cloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters
AT kailashpbhatia cloudupdrssmartphonesoftwareinparkinsonsstudycrossvalidationagainstblindedhumanraters
_version_ 1724384349881630720